首页> 外文期刊>Advanced functional materials >Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics
【24h】

Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

机译:Nanomaterials Responsive to Endogenous Biomarkers for Cardiovascular Disease Theranostics

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiovascular disease (CVD) is the number one cause of death worldwide,which propels the development of advanced technologies for CVD diagnosisand treatment. Biomarker-responsive nanomaterials are appealing therapeuticplatforms that provide new horizons for CVD theranostics. In thisreview, recent advances in nanomaterials with endogenous biomarkers asstimuli or targets for CVD theranostics is presented. First, the categories ofbiomarkers involved are comprehensively itemized based on pathologicalmechanisms including pH, reactive oxygen species, lipids, enzymes, macrophagereceptors, subendothelium components, platelet receptors, inflammation,and osteopontin. The role of these biomarkers in bridge-buildingbetween nanomaterials and CVD is then presented. Next, the biomedicalapplications of nanomaterials responsive to endogenous biomarkers asstimuli or targets for the diagnosis and treatment of CVD are elaborated.Finally, the challenges and future research directions of biomarker-responsivenanomaterials in CVD are also discussed. This review will provide scientificguidance to facilitate clinical applications of biomarker-responsivenanomaterials.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号